Quadrant Capital Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-64
| Closed | -$1K | – | 2886 |
|
2022
Q3 | $1K | Buy |
+64
| New | +$1K | ﹤0.01% | 2601 |
|
2022
Q1 | – | Sell |
-571
| Closed | -$9K | – | 2751 |
|
2021
Q4 | $9K | Sell |
571
-8
| -1% | -$126 | ﹤0.01% | 1697 |
|
2021
Q3 | $9K | Buy |
+579
| New | +$9K | ﹤0.01% | 1673 |
|
2021
Q2 | – | Sell |
-9
| Closed | – | – | 2617 |
|
2021
Q1 | $0 | Sell |
9
-6
| -40% | – | ﹤0.01% | 2484 |
|
2020
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 2403 |
|
2019
Q3 | – | Sell |
-279
| Closed | -$22K | – | 2413 |
|
2019
Q2 | $22K | Buy |
+279
| New | +$22K | ﹤0.01% | 1617 |
|
2017
Q2 | – | Sell |
-44
| Closed | -$4K | – | 2110 |
|
2017
Q1 | $4K | Sell |
44
-152
| -78% | -$13.8K | ﹤0.01% | 1436 |
|
2016
Q4 | $21K | Sell |
196
-44
| -18% | -$4.71K | 0.01% | 745 |
|
2016
Q3 | $38K | Buy |
240
+198
| +471% | +$31.4K | 0.02% | 529 |
|
2016
Q2 | $5K | Buy |
+42
| New | +$5K | ﹤0.01% | 1244 |
|
2016
Q1 | – | Sell |
-60
| Closed | -$8K | – | 2043 |
|
2015
Q4 | $8K | Buy |
+60
| New | +$8K | 0.01% | 885 |
|